Medicine
Thiamine 200 mg/2 mL injection
Thiamine 200 mg/2 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 20 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77° F). PROTECT FROM LIGHT.
Key facts
- Active ingredient (INN)
- Thiamine
- Brand
- Sold under the generic name
- Strength
- 200 mg/2 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 25 vials of 2 mL, 2 mL, 25 pouches of 2 mL and 22 more
- Manufacturers
- Avet PharmaceuticalsIndiaCamber PharmaceuticalsIndiaCaplin SterilesIndiaDr. Reddy's LaboratoriesIndiaEugiaIndiaGland PharmaIndiaLifestar PharmaIndiaFresenius KabiHealthFirstHenry Schein
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77° F). PROTECT FROM LIGHT.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A11DA01 Thiamine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2000
- Identifiers
- RxCUI 313324DailyMed set ID c4896996-cac8-44df-aa36-82e2b567c3b6, 764d608a-d821-4447-85e1-6af297abb4c1, 5982cf83-01d6-4acb-8373-339079b8a76e +21NDC 72603-565, 23155-933, 25021-500 +19Application ANDA218471, ANDA217181, ANDA206106 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 2 mL in 1 vial | 23155-933-41 | Avet PharmaceuticalsIndia | 15 November 2025 |
| 25 vial, multi-dose in 1 tray / 2 mL in 1 vial, multi-dose | 31722-363-32 | Camber PharmaceuticalsIndia | 6 November 2024 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 65145-129-25 | Caplin SterilesIndia | 20 May 2024 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 43598-050-25 | Dr. Reddy's LaboratoriesIndia | 31 March 2023 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 55150-273-25 | EugiaIndia | 20 April 2022 |
| 25 vial in 1 carton / 2 mL in 1 vial | 68083-567-25 | Gland PharmaIndia | 24 February 2025 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 70756-684-25 | Lifestar PharmaIndia | 1 October 2026 |
| 25 vial, multi-dose in 1 tray / 2 mL in 1 vial, multi-dose | 63323-013-02 | Fresenius Kabi | 1 September 2000 |
| 25 vial, multi-dose in 1 tray / 2 mL in 1 vial, multi-dose | 63323-013-09 | Fresenius Kabi | 1 September 2000 |
| 25 vial, multi-dose in 1 tray / 2 mL in 1 vial, multi-dose | 63323-013-26 | Fresenius Kabi | 1 September 2000 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 72485-507-25 | Armas Pharmaceuticals | 22 May 2023 |
| 25 vial in 1 carton / 2 mL in 1 vial | 72266-260-25 | Fosun Pharma | 6 February 2026 |
| 25 vial in 1 carton / 2 mL in 1 vial | 0641-6228-25 | Hikma Pharmaceuticals | 12 February 2021 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 71288-804-03 | Meitheal Pharmaceuticals | 25 September 2026 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 67457-196-02 | Mylan Institutional | 4 June 2013 |
| 25 vial in 1 carton / 2 mL in 1 vial | 83270-004-03 | Onesource Specialty Pharma | 27 February 2026 |
| 25 vial in 1 carton / 2 mL in 1 vial | 25021-500-02 | Sagent Pharmaceuticals | 20 January 2021 |
| 2 mL in 1 vial, multi-dose | 51662-1523-1 | HealthFirst | 14 June 2021 |
| 25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 2 mL in 1 vial, multi-dose | 51662-1523-3 | HealthFirst | 10 November 2022 |
| 25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 2 mL in 1 vial, multi-dose | 51662-1635-3 | HealthFirst | 26 September 2023 |
| 1 vial, multi-dose in 1 bag / 2 mL in 1 vial, multi-dose | 0404-9799-20 | Henry Schein | 17 September 2024 |
| 1 vial, multi-dose in 1 bag / 2 mL in 1 vial, multi-dose | 0404-9963-02 | Henry Schein | 12 January 2022 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 72603-139-25 | NorthStar Rx | 20 April 2023 |
| 25 vial, multi-dose in 1 carton / 2 mL in 1 vial, multi-dose | 72603-565-25 | NorthStar RxLLC | 14 October 2026 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70518-4230-0 | Remedyrepack | 13 November 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Thiamine is a prescription medicine indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure, among other approved uses. It is available as injection for intramuscular and intravenous use. MedsAcross supplies Thiamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ThiamineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Thiamine Hydrochloride prescribing information (Meitheal Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Thiamine 200 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.